Acrolein, an environmental toxicant and its applications to in vivo and in vitro atherosclerosis models: An update

Environ Toxicol Pharmacol. 2022 Jul:93:103890. doi: 10.1016/j.etap.2022.103890. Epub 2022 May 22.

Abstract

Cardiovascular disease, the foremost cause of death worldwide, is an overarching disease term that encompasses a number of disorders involving the heart and circulatory system, including atherosclerosis. Atherosclerosis is a primary cause of cardiovascular diseases and is caused by buildup of plaque and narrowing of blood vessels. Epidemiological studies have suggested that environmental pollutants are implicated in atherosclerosis disease progression. Among many environmental pollutants, acrolein (Acr) is an abundant reactive aldehyde and is ubiquitously present in cigarette smoke as well as food products (e.g., overheated oils and wine). Despite its ubiquitous presence and potential impact on the etiology of cardiovascular disease, a limited consensus has been made in regard to Acr exposure conditions to induce atherosclerosis in vivo. This mini-review summarizes in vivo atherosclerosis models using Acr to investigate biochemical and phenotypic changes related to atherosclerosis and in vitro mechanistic studies involving Acr and atherosclerosis.

Keywords: Acrolein; Atherosclerosis; Cardiovascular diseases; Environmental toxicant.

Publication types

  • Review

MeSH terms

  • Acrolein / toxicity
  • Aldehydes
  • Atherosclerosis* / chemically induced
  • Cardiovascular Diseases*
  • Environmental Pollutants*
  • Hazardous Substances
  • Humans

Substances

  • Aldehydes
  • Environmental Pollutants
  • Hazardous Substances
  • Acrolein